Herbas VPB

Print
EN | LT
LT - Tirpios guanilatciklazės (SGC) stimuliatoriai/aktyvatoriai derinyje su NEP inhibitoriumi ir (arba) angiotenzino AII antagonistu ir jų naudojimas
EN - STIMULATORS / ACTIVATORS OF SOLUBLE GUANYLAT CYCLASE IN COMBINATION WITH A NEP-INHIBITOR AND AN ANGIOTENSIN AII-ANTAGONIST AND THE USE THEREOF

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 45/06 (2006.01)
A61K 31/216 (2006.01)
A61K 31/41 (2006.01)
A61K 31/506 (2006.01)
A61K 31/519 (2006.01)
A61P 9/00 (2006.01)
A61P 3/14 (2006.01)
A61P 7/02 (2006.01)
A61P 7/10 (2006.01)
A61P 9/04 (2006.01)
A61P 11/00 (2006.01)
A61P 13/12 (2006.01)
A61P 43/00 (2006.01)
A61P 3/06 (2006.01)
European patent
(11) Number of the document 3325013
(13) Kind of document T
(96) European patent application number 16739146.5
Date of filing the European patent application 2016-07-15
(97) Date of publication of the European application 2018-05-30
(45) Date of publication and mention of the grant of the patent 2020-09-23
(46) Date of publication of the claims translation 2020-11-10
PCT application
(86) Number PCT/EP2016/066891
Date 2016-07-15
PCT application publication
(87) Number WO 2017/013010
Date 2017-01-26
Priority applications
(30) Number Date Country code
15178141 2015-07-23 EP
Inventors
(72)
MARQUARDT, Tobias, DE
FOLLMANN, Markus, DE
STASCH, Johannes-Peter, IT
Grantee
(73) Bayer Pharma Aktiengesellschaft, Müllerstrasse 178, 13353 Berlin, DE
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Tirpios guanilatciklazės (SGC) stimuliatoriai/aktyvatoriai derinyje su NEP inhibitoriumi ir (arba) angiotenzino AII antagonistu ir jų naudojimas
  STIMULATORS / ACTIVATORS OF SOLUBLE GUANYLAT CYCLASE IN COMBINATION WITH A NEP-INHIBITOR AND AN ANGIOTENSIN AII-ANTAGONIST AND THE USE THEREOF
Last renewal fee
Payment date Validity (years) Amount
2025-06-18 10 231.00 EUR
Next renewal fee
2026-07-15